COST-EFFECTIVENESS OF DIRECT ORAL ANTICOAGULANTS (DOACS) VERSUS LOW-MOLECULARWEIGHT HEPARINS (LMWH) IN PATIENTS WITH CANCERASSOCIATED VENOUS THROMBOEMBOLISM (CAT) IN HONG KONG

被引：0
|
作者：
Kang, W. [1 ]
Peng, K. [2 ]
Yan, V [2 ]
Chan, E. W. [2 ]
机构：
[1] Univ Hong Kong, 91, Hong Kong, Peoples R China
[2] Univ Hong Kong, Hong Kong, Peoples R China
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE522
引用
收藏
页码：S152 / S152
页数：1
相关论文
共 47 条
  • [1] Cost-Effectiveness of Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation in Hong Kong
    Peng, Kuan
    Li, Yihua
    Chan, Esther W.
    Wong, Ian C. K.
    Li, Xue
    VALUE IN HEALTH REGIONAL ISSUES, 2023, 36 : 51 - 57
  • [2] Cost-effectiveness of direct oral anticoagulants (DOAC) versus low-molecular weight heparin (LMWH) For treatment of venous thromboembolism (VTE) in gastrointestinal (GI) cancer patients
    Shin, Young Eun
    Wu, Wenchen
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 415 - 415
  • [3] Cost-effectiveness of apixaban versus other direct oral anticoagulants and low-molecular-weight-heparins for cancer associated venous thromboembolism in Spain.
    Munoz Martin, Andres J.
    Diaz, Enrique Gallardo
    Crespo, Carlos
    Domenech, Roma Masana
    Soto, Javier
    Arumi, Daniel
    Fernandez, Susana
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [4] Direct Oral Anticoagulants (DOACs) Vs. Low Molecular Weight Heparins (LMWH) for Venous Thromboembolism (VTE) in Patients with Primary Brain Tumors or Secondary Brain Metastases
    Lee, Angela
    Oley, Frank, Jr.
    Lo, Mimi
    Fong, Richard
    McGann, Mary
    Saunders, Ila
    Block, Shanna
    Mahajan, Anjlee
    Pon, Tiffany
    BLOOD, 2020, 136
  • [5] Cost-effectiveness of direct oral anticoagulants compared to low-molecular-weight-heparins for treatment of cancer associated venous thromboembolism in Spain
    Munoz, Andres
    Gallardo, Enrique
    Agnelli, Giancarlo
    Crespo, Carlos
    Forghani, Monica
    Arumi, Daniel
    Fernandez de Cabo, Susana
    Soto, Javier
    JOURNAL OF MEDICAL ECONOMICS, 2022, 25 (01) : 840 - 847
  • [6] Cost-effectiveness of direct oral anticoagulants for cancer-associated venous thromboembolism
    King, J.
    Bhat, S.
    Heath, L. J.
    Derington, C. G.
    Yu, Z.
    Clark, N. P.
    Witt, D. M.
    Reynolds, K.
    Lang, D. T.
    Xu, S.
    Bellows, B. K.
    EUROPEAN HEART JOURNAL, 2019, 40 : 3140 - 3140
  • [7] Cost-Effectiveness Analysis of Direct Oral Anticoagulants Versus Vitamin K Antagonists for Venous Thromboembolism in China
    Sun, Ke-Xin
    Cui, Bin
    Cao, Shan-Shan
    Huang, Qi-Xiang
    Xia, Ru-Yi
    Wang, Wen-Jun
    Wang, Jing-Wen
    Yu, Feng
    Ding, Yi
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [8] Evaluation of direct oral anticoagulants versus low molecular weight heparins for venous thromboembolism treatment in patients with gastrointestinal malignancies
    Guan, Tiffany
    Laguna, Arianna
    Soares, Alisha
    Legasto, Carlo S.
    Block, Shanna
    Saunders, Ila M.
    Alvarez, Kathryn
    Pon, Tiffany
    Patel, Nimish
    Mahajan, Anjlee
    Lee, Angela
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2023, 56 (03) : 439 - 446
  • [9] Evaluation of direct oral anticoagulants versus low molecular weight heparins for venous thromboembolism treatment in patients with gastrointestinal malignancies
    Tiffany Guan
    Arianna Laguna
    Alisha Soares
    Carlo S. Legasto
    Shanna Block
    Ila M. Saunders
    Kathryn Alvarez
    Tiffany Pon
    Nimish Patel
    Anjlee Mahajan
    Angela Lee
    Journal of Thrombosis and Thrombolysis, 2023, 56 : 439 - 446
  • [10] Direct oral anticoagulants or low-molecular-weight heparins for venous thromboembolism in patients with brain tumors
    Lee, Angela
    Oley, Frank, Jr.
    Lo, Mimi
    Fong, Richard
    McGann, Mary
    Saunders, Ila
    Block, Shanna
    Mahajan, Anjlee
    Pon, Tiffany K.
    THROMBOSIS RESEARCH, 2021, 208 : 148 - 155
12345